Related by context. All words. (Click for frequent words.) 75 PREOS 75 GATTEX 72 PREOS R 72 PROMACTA 72 elotuzumab 71 Gattex 70 Triolex 70 forodesine 70 TELINTRA 70 vidofludimus 70 Nasulin 70 ZOLINZA 69 LibiGel ® 69 PSN# [002] 69 Phenoptin 69 Dacogen injection 69 Alzhemed TM 69 JAK inhibitor 69 CoFactor 69 Fibrillex TM 69 FOLOTYN ® 69 alvespimycin 68 PEG SN# 68 phase IIa clinical 68 Azedra 68 oral prodrug 68 GATTEX ® 68 Androxal TM 68 eltrombopag 68 RSD# oral 68 hypoparathyroidism 68 phase IIb clinical 68 squalamine 68 vismodegib 68 PRT# 68 eniluracil 68 urocortin 2 68 Amrubicin 68 alvimopan 68 lubiprostone 67 GATTEX TM 67 Phase IIIb clinical 67 Phase 2a trial 67 PDE4 inhibitor 67 EOquin 67 INCB# [001] 67 registrational 67 R#/MEM # 67 diabetic neuropathic pain 67 Mipomersen 67 ruxolitinib 67 AZILECT R 67 MYDICAR 67 CCX# 67 FOLOTYN 67 PEGPH# 67 subcutaneous formulation 67 lomitapide 67 Phase IIa trials 67 AZILECT ® 67 axitinib 67 anticancer compound 67 PLK1 SNALP 67 EOquin TM 67 LEUKINE 67 Triapine R 67 Plicera 67 Dasatinib 67 IPLEX 67 Pivotal Phase III 66 Archexin 66 CR# vcMMAE 66 brivaracetam 66 nitazoxanide 66 Neurodex 66 methylnaltrexone 66 lumiliximab 66 phase IIb 66 HuMax EGFr 66 bicifadine 66 ISIS # 66 riociguat 66 EVIZON 66 Increlex ® 66 TKM ApoB 66 AQ4N 66 Marqibo 66 Raptiva ® 66 IL# PE#QQR 66 HuLuc# 66 Phase Ib clinical 66 Phase 1b trial 66 CAPHOSOL 66 Phase IIb clinical 66 TELCYTA 66 pomalidomide 66 MEK inhibitor 66 ozarelix 66 Fx #A 66 CIMZIA ™ 66 ONTAK 66 Phase 2b study 66 tafamidis 66 phase IIb trial 66 cannabinor 66 TYZEKA 66 tasimelteon 66 torezolid phosphate 66 teriflunomide 66 MoxDuo IR 66 octreotide implant 66 Plenaxis TM 66 Civacir 66 6R BH4 66 ularitide 66 NEBIDO 66 Cethrin 66 HuMax CD4 66 cobiprostone 66 tanespimycin 66 CIMZIA TM 66 tezampanel 66 enzastaurin 66 PHX# 66 Bronchitol 66 mertansine 66 atacicept 65 Phase Ib study 65 nonclinical studies 65 Icatibant 65 Corlux 65 RLY# 65 Bicifadine 65 Phase 2b trial 65 pradefovir 65 Privigen 65 cinacalcet HCl 65 Phase Ib II 65 preclinical pharmacokinetic 65 apremilast 65 Tarceva TM 65 incyclinide 65 huC# DM4 65 Traficet EN 65 vilazodone 65 CINTREDEKIN BESUDOTOX 65 Capesaris 65 Gabapentin GR 65 SILENOR TM 65 Sym# 65 ataluren 65 Amplimexon 65 LAF# 65 Zorbtive TM 65 hyperphenylalaninemia HPA due 65 GATTEX ™ 65 Nuvion 65 PXD# 65 APTIVUS 65 HGS ETR1 65 INTEGRILIN 65 lintuzumab 65 desvenlafaxine succinate 65 Catena ® 65 Cellegesic 65 budesonide foam 65 ospemifene 65 phase IIa 65 eculizumab 65 Phase III clinical 65 fosbretabulin 65 ganetespib 65 dextromethorphan quinidine 65 Proellex TM 65 BAY #-# 65 LEP ETU 65 Phase IIa trial 65 rALLy trial 65 rosuvastatin calcium 65 refractory gout 65 lapatinib Tykerb 65 TH# [003] 65 RSD# 65 Phase 1a clinical 65 Androxal 65 Bezielle 65 pitavastatin 65 Zenvia ™ 65 Rebif ® 65 Zerenex 65 balsalazide tablet 65 JANUVIA 65 bazedoxifene 65 Vilazodone 65 ruboxistaurin 65 PEG PAL 65 Tolvaptan 65 Glypromate 65 Golimumab 65 INCB# [002] 65 indiplon capsules 65 diarrhea predominant irritable 65 rhThrombin 65 albinterferon alfa 2b 65 VA# [002] 65 ocrelizumab 65 ACTEMRA TM 65 ATryn ® 65 Cleviprex TM clevidipine 65 Xanafide 65 GAMMAGARD 65 Trofex 65 oral ridaforolimus 65 BCX# 65 Factor VIIa 65 elagolix 65 clevudine 65 PEG INTRON 65 USL# 65 ThGRF 65 maximally tolerated dose 65 MAXY G# 65 TLK# 65 YONDELIS 65 sorafenib Nexavar 65 Asentar 65 Cimzia TM 65 KNS # 65 TBC# 65 ALN PCS 65 sunitinib malate 65 ORENCIA ® 65 docetaxel Taxotere ® 65 SNT MC# 65 dalbavancin 64 Ostarine 64 Alocrest 64 PEG Interferon lambda 64 DAVANAT 64 cilengitide 64 Phase IIa clinical 64 rhIGF-I/rhIGFBP-3 64 MYCAMINE 64 casopitant 64 nalbuphine ER 64 PS# [001] 64 Onrigin 64 Cetrorelix 64 ATPace TM 64 Myocet 64 OvaRex ® MAb 64 vandetanib 64 Panzem 64 ENMD # 64 plasma kallikrein inhibitor 64 Zybrestat 64 obatoclax 64 ATryn R 64 Onconase 64 Proquin XR 64 elacytarabine 64 methylnaltrexone bromide 64 E2F Decoy 64 sitaxsentan 64 VEGF Trap 64 placebo controlled clinical 64 Zenvia Phase III 64 HGS# 64 THALOMID 64 KAPIDEX 64 investigational compound 64 AMEVIVE 64 Phase IIb clinical trials 64 AVN# [001] 64 Raptiva R 64 Tamibarotene 64 ACAPODENE 64 CEQ# 64 sorafenib tablets 64 Arranon 64 Eltrombopag 64 thymalfasin 64 Dextofisopam 64 Sanctura XR 64 pharmacokinetic PK study 64 Insegia 64 dirucotide 64 talactoferrin 64 C1 INH 64 ISTODAX 64 Saforis 64 TOLAMBA 64 fostamatinib 64 Preos 64 efalizumab 64 Natalizumab 64 pan HDAC inhibitor 64 nab paclitaxel 64 rNAPc2 64 investigational drug 64 Panzem R NCD 64 briakinumab 64 Phase IIb 64 Aloxi injection 64 ATL/TV# 64 serotonin norepinephrine reuptake inhibitor 64 orBec 64 Vaprisol 64 varespladib 64 Acapodene 64 APD# 64 Targretin 64 mapatumumab 64 Nexavar sorafenib 64 Proxinium TM 64 ORENCIA R 64 Hyphanox 64 Elagolix 64 GED aPC 64 Cloretazine 64 RHUCIN 64 Cimzia ® 64 otelixizumab 64 GSK# [001] 64 Adlea 64 CORT # 64 Phase IIB 64 TACI Ig 64 sodium thiosulfate STS 64 ELADUR 64 perifosine 64 alagebrium 64 pioglitazone HCl 64 ADAGIO study 64 TNF alpha inhibitor 64 Phase 2b clinical 64 velafermin 64 blinatumomab 64 crizotinib PF # 64 Desmoteplase 64 ELND# 64 EVIZON TM 64 decitabine 64 dose cohort 64 glufosfamide 64 Clonicel 64 VAPRISOL 64 telbivudine 64 plasma pharmacokinetics 64 CA4P 64 Ereska 64 rFIXFc 64 DPP4 inhibitor 64 Androxal ® 64 celgosivir 64 EFAPROXYN 64 Azilect ® 64 Chemophase 64 clinical pharmacology studies 64 MERLIN TIMI 64 LymphoStat B 64 SILENOR 64 bardoxolone methyl 64 Prodarsan 64 Phase III Clinical Trial 64 CTAP# Capsules 63 Dapagliflozin 63 peginesatide 63 oxypurinol 63 PRX # 63 pharmacokinetic PK profile 63 BARACLUDE R 63 Rasilez Tekturna 63 TOCOSOL Paclitaxel 63 Spiegelmer ® 63 UPLYSO 63 angiogenesis inhibitor 63 AEGR 63 Phase IIb trials 63 MAA submission 63 Targretin capsules 63 Anturol TM 63 MGCD# [001] 63 Marqibo TM 63 LIALDA 63 eprotirome 63 dacetuzumab 63 BLA filing 63 Xcytrin R 63 desvenlafaxine 63 Diamyd ® 63 Telintra 63 RGB # 63 Tracleer R 63 Neulasta ® 63 dexpramipexole 63 Phase III trials 63 EndoTAG TM -1 63 TRISENOX 63 Tezampanel 63 oral salmon calcitonin 63 DDP# 63 AVE# 63 Chrysalin 63 Aryplase 63 Ophena TM 63 oxaliplatin Eloxatin 63 PSMA ADC 63 Vandetanib 63 faropenem 63 linaclotide 63 Cloretazine R VNP#M 63 Anturol 63 Panzem R 63 INCB# [003] 63 bifeprunox 63 mGluR5 NAM 63 QNEXA 63 omacetaxine 63 Phase 2b 63 FTY# 63 pivotal Phase III 63 AEG# 63 tipranavir 63 OPAXIO 63 #D#C# 63 KRN# 63 Phase Ib 63 NV1FGF 63 Tasimelteon 63 prucalopride 63 calcitonin 63 omecamtiv mecarbil 63 visilizumab 63 Zemplar Capsules 63 pharmacodynamic profile 63 IV APAP 63 pharmacokinetic PK 63 oxymorphone ER 63 Virulizin R 63 TORISEL 63 INC# 63 preclinically 63 GALNS 63 ELACYT 63 Phase III Clinical Trials 63 sargramostim 63 TREDAPTIVE 63 oral methylnaltrexone 63 Sandostatin LAR 63 COMFORT II 63 ToGA 63 MYDICAR ® 63 OHR/AVR# 63 PRADAXA 63 febuxostat 63 angiographic outcomes 63 regadenoson 63 ORMD 63 lanthanum carbonate 63 PrevOnco ™ 63 Aflibercept 63 Hedgehog antagonist 63 Phase IIIb study 63 favorable pharmacokinetic profile 63 docetaxel Taxotere R 63 Cimzia ® certolizumab pegol 63 ofatumumab 63 glucokinase activator 63 ONCONASE R 63 abiraterone acetate 63 LY# [003] 63 PROVIGIL 63 GTC recombinant human 63 zanolimumab 63 Phase III Pivotal 63 Phase 1b clinical 63 Torisel 63 cinacalcet 63 rhC1INH 63 Menerba 63 PEGINTRON TM 63 NP2 Enkephalin 63 Dalbavancin 63 Amigal 63 generation purine nucleoside 63 Lixivaptan 63 CD# CEA 63 HuMax CD# 63 ASONEP 63 intermittent dosing 63 MNTX 63 subcutaneously administered 63 PF # [001] 63 Evoltra 63 romiplostim 63 ARIKACE 63 reslizumab 63 Urocortin 2 63 ALGRX 63 MAGE A3 ASCI 63 ridaforolimus 63 phase IIb study 63 neratinib 63 Phenserine 63 pharmacokinetic profile 63 pramlintide 63 clevidipine 63 pain palliation 63 Lubiprostone 63 IRESSA 63 MAP# 63 PRECISE trial 63 vosaroxin 63 Campath ® 63 postoperative ileus 63 BYDUREON 63 MIRCERA 63 lucinactant 63 Virulizin ® 63 NGX# 63 coadministration 63 Symadex 63 terlipressin 63 candesartan cilexetil 63 PRTX 63 AP# [003] 63 Phase III clinical trials 63 HeFH 63 oral deforolimus 63 Emselex 63 valopicitabine 63 Zingo TM 63 OMNARIS HFA 63 aflibercept VEGF Trap 63 mipomersen 63 preclinical studies 63 ponatinib 63 GLP toxicology studies 63 HGS ETR2 63 REMICADE ® 63 Aurexis 63 oral FTY# 63 Tavocept 63 indibulin 63 rilonacept 63 Revimmune 63 Prodarsan ® 63 tiapamil 63 Kepivance 63 analgesic efficacy 63 TYKERB 63 Alfimeprase 63 Phase IIa 63 midstage clinical 63 Prosaptide 63 Aclidinium 63 TEMODAL 63 edoxaban 63 Viprinex TM 63 LIVALO 63 Inhalation Solution 63 ACTEMRA 63 VPRIV 63 interferon beta 1b 63 COPAXONE R 63 DR Cysteamine 63 OMNARIS Nasal Spray 63 AzaSite Plus 63 RoACTEMRA 63 Trizytek 63 HQK 63 Cinryze ™ 63 Betaferon R 63 DEXILANT 63 fidaxomicin 62 Omigard 62 liprotamase 62 Toremifene 62 posaconazole 62 Phase 2a clinical 62 #I TM# 62 alefacept 62 atrasentan 62 Xinlay 62 MabCampath 62 IND submission 62 Leukine 62 HspE7 62 amrubicin 62 Troxatyl 62 TRO# 62 Viprinex 62 dosing cohort 62 Amitiza 62 GnRH antagonist 62 APF# 62 Firazyr 62 metreleptin 62 receptor tyrosine kinase inhibitor 62 Zoraxel 62 Octreotide 62 Rezular 62 docetaxel chemotherapy 62 GAMMAGARD LIQUID 62 ZYBRESTAT 62 Protexia R 62 ApoB SNALP 62 ADVEXIN 62 GFT# 62 acyclovir Lauriad R 62 nucleoside analog 62 ThermoDox R 62 Urocidin TM 62 BLA submission 62 QLT# 62 Technosphere Insulin 62 Nanobody 62 SPIRIVA HandiHaler 62 bardoxolone 62 ACZ# 62 CYT# 62 Ozarelix 62 RDEA# 62 ProSavin 62 Degarelix 62 novel histone deacetylase 62 NUEDEXTA 62 Memryte 62 Stimuvax R 62 ALN RSV# 62 CINOD 62 Apoptone 62 dose cohorts 62 deferasirox 62 FOSRENOL R 62 tolevamer 62 placebo controlled clinical trials 62 Evoltra ® 62 selective androgen receptor modulator 62 Soliris eculizumab 62 Rhucin R 62 Phase #b/#a 62 RAPTIVA 62 Shigamabs ® 62 mTOR inhibition 62 omacetaxine mepesuccinate 62 GGF2 62 AeroLEF TM 62 rBChE 62 Fludara 62 Acetavance 62 BRIM2 62 selective modulator 62 investigational hepatitis C 62 DU #b 62 deferiprone 62 Zelapar 62 ecallantide 62 inhaled iloprost 62 PhosLo 62 investigational monoclonal antibody 62 TG# [003] 62 Q#IR 62 clinical trial 62 ancrod 62 Dacogen decitabine 62 Betaferon ® 62 Kuvan 62 satraplatin 62 Darusentan 62 ARIKACE ™ 62 rotigotine transdermal patch 62 wilate ® 62 Genasense ® oblimersen 62 Cancidas 62 Pimavanserin 62 odanacatib 62 ALN TTR# 62 STELARA 62 SUTENT 62 YERVOY 62 Tyrima 62 Restanza 62 #ME# 62 pegloticase 62 CaPre TM 62 Huntexil 62 regorafenib 62 Squalamine 62 REVLIMID R 62 BrachySil TM 62 HCD# [002] 62 PROVENGE sipuleucel T 62 POSIDUR TM 62 Serdaxin 62 Sulonex TM 62 ZACTIMA 62 senicapoc 62 Noxafil 62 trastuzumab DM1 T DM1 62 ULORIC 62 custirsen 62 MGd 62 BENICAR HCT 62 T Pred 62 pharmacodynamic effects 62 metaglidasen 62 Aplidin 62 TRANSDUR Sufentanil 62 RELOVAIR ™ 62 Clolar ® 62 ZYFLO 62 Increlex R 62 DXL# 62 CG# [003] 62 orally dosed 62 Nebido 62 Neuradiab 62 RG# [001] 62 Onco TCS 62 dimebon 62 interferon gamma 1b 62 liposomal formulation 62 GRN# 62 double blinded placebo 62 aplindore 62 dyskinesia PD LID 62 preclinical 62 hoFH 62 Zensana TM 62 Alvesco R 62 ATL# [001] 62 catheter occlusion 62 REYATAZ R 62 miconazole Lauriad ® 62 Focalin XR 62 Ophena 62 S/GSK# 62 deforolimus 62 Mycamine 62 confirmatory Phase III 62 CYCLOSET 62 Entereg R 62 Safinamide 62 pertuzumab 62 placebo controlled Phase 62 Afatinib 62 tecarfarin 62 Cimzia R 62 arzoxifene 62 PANVAC VF 62 Somatuline R Autogel R 62 CANCIDAS 62 MBP# [001] 62 rALLy clinical trial 62 vernakalant oral 62 HCV protease inhibitor 62 OncoVEX GM CSF 62 Ataluren 62 Debio 62 trospium 62 cangrelor 62 guanfacine extended release 62 Phase #/#a trial 62 bicalutamide 62 Phase 1b 62 Vidaza azacitidine 62 baminercept 62 AMITIZA 62 NUVIGIL 62 multicenter Phase III 62 ranolazine 62 MGCD# [002] 62 PEGylated interferon beta 1a 62 APOPTONE 62 rindopepimut 62 pralatrexate 62 REVLIMID lenalidomide 62 pseudobulbar affect PBA 62 HoFH 62 FAMPYRA 62 IMA# 62 ROZEREM TM 62 Onalta 62 metastatic HRPC 62 adalimumab Humira 62 oral anticoagulant 62 dexanabinol 62 relapsed multiple myeloma 62 renal toxicity 62 histamine dihydrochloride 62 palonosetron 62 Prestara 62 Gliadel Wafer 62 Neupro R 62 Soriatane 62 Viramidine 62 synthetic retinoid 62 verteporfin 62 eculizumab therapy 62 including eniluracil ADH 62 systemically administered 62 galiximab 62 Zavesca R 62 Calcium Acetate 62 goserelin 62 PEGylated anti 62 alemtuzumab Campath 62 pharmacodynamic PD 62 efficacy tolerability 62 Valdoxan 62 ramelteon 62 davunetide intranasal AL 62 UVIDEM 62 THR beta agonist 62 R#/MEM 62 Phase Ia 62 Laquinimod 62 Seliciclib 62 ISENTRESS 62 OXi# 62 ZEGERID Capsules 62 azacitidine 62 MACUGEN 62 Genasense R oblimersen 62 novel VDA molecule 61 NPSP# 61 telaprevir VX 61 Rasagiline 61 ascending dose 61 preclinical efficacy 61 ACV1 61 Microplasmin 61 Acute Ischemic Stroke 61 EP #R 61 PDX pralatrexate 61 EVIZON TM squalamine lactate 61 relapsed MM 61 CRLX# 61 LEVADEX ™ 61 PREGNANT Study 61 thalidomide Thalomid 61 Actimmune ® 61 phase IIIb 61 EDARBI 61 Pirfenidone 61 oral calcitonin 61 SomatoKine 61 BRIM3 61 LE SN# 61 REVLIMID ® 61 opioid induced bowel dysfunction 61 Quinamed 61 KYNAPID 61 PROCHYMAL 61 Febuxostat 61 LT NS# 61 DepoDur TM 61 romidepsin 61 viral kinetics 61 ZYBRESTAT fosbretabulin 61 MEK inhibitor RDEA# 61 cediranib 61 BENLYSTA ® 61 ribavirin USP 61 painful diabetic neuropathy 61 Defibrotide 61 REMINYL ® 61 MLN# 61 pharmacokinetic studies 61 SIR Spheres 61 Frova ® 61 phase Ib 61 pexelizumab 61 ITAX 61 Cardio Vascu Grow 61 tranilast 61 renal anemia 61 proton pump inhibitor PPI 61 cetrorelix 61 Reclast Aclasta 61 iniparib 61 INTEGRILIN ® 61 Azedra TM 61 ulimorelin 61 clinicaltrials 61 treprostinil 61 azficel T 61 mesylate tablets 61 Glatiramer Acetate 61 #mg dose [001] 61 inhibitor RG# 61 clinical trials 61 Omacetaxine 61 Allovectin 7 ® 61 ROTATEQ 61 Rhucin 61 glatiramer acetate 61 RAPAFLO 61 Exherin TM 61 darusentan 61 highly selective inhibitor 61 ALN TTR 61 Complete Response 61 Phase IIIb 61 alfimeprase 61 Phase IIb trial 61 pharmacodynamic properties 61 bevasiranib 61 APEX PD 61 APTIVUS r 61 ALTU 61 dextofisopam 61 Aviptadil 61 fenofibric acid 61 GetGoal Phase III 61 ABILIFY ® 61 tocilizumab 61 ADVANCE PD 61 SAR# [004] 61 dose limiting toxicities 61 anti leukemic 61 CBLC# 61 Mepact 61 antitumor effects 61 Phase III 61 aclidinium 61 Methylnaltrexone 61 dose escalation Phase 61 Orathecin 61 HepaSphere 61 Pivotal Phase 61 ganaxolone 61 Surfaxin LS 61 miglustat 61 antidiabetic drug 61 LymphoStat B TM 61 BARACLUDE ® 61 Abbokinase 61 FIRAZYR 61 superficial bladder cancer 61 Ambrisentan 61 evaluating tivozanib 61 Cimzia certolizumab pegol 61 eszopiclone 61 trodusquemine 61 galantamine 61 Allovectin 7 R 61 RECOTHROM 61 SAR# [002] 61 rasagiline tablets 61 erlotinib Tarceva ® 61 Loramyc R 61 Velcade bortezomib 61 CIMZIA TM certolizumab pegol 61 JZP 61 laquinimod 61 tipifarnib 61 Telavancin 61 XL# [003] 61 FASLODEX 61 Cloretazine ® 61 aprepitant 61 PEP# [003] 61 trastuzumab Herceptin ® 61 Naglazyme 61 AGILECT R 61 Tocosol Paclitaxel 61 ACOMPLIA R 61 Tekamlo 61 lasofoxifene 61 picoplatin 61 eosinophilic asthma 61 EDEMA3 61 Amoxicillin PULSYS 61 alemtuzumab MS 61 FDA Approvable Letter 61 Vivaglobin 61 amifostine 61 Nexavar ® 61 adipiplon 61 BNC# 61 Ventavis 61 ostarine 61 SCH # 61 inhaled liposomal ciprofloxacin 61 Ceflatonin 61 Ferinject 61 nucleotide analog 61 AMITIZA R 61 eritoran 61 Stedivaze 61 FACTIVE R gemifloxacin 61 Entereg TM 61 PRISTIQ 61 dose proportionality 61 Natural S equol 61 PEG uricase